Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan K Shields

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 18, 2021
Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysisSunish Shah, Derek N Bremmer, Ellen G Kline, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2025
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative MeningitisAlice J Hsu, Kathleen Chiotos, Emily L Heil, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2025
Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremiaSunish Shah, Lloyd G Clarke, Bonnie A Falcione, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam ResistanceRyan K Shields, M Hong Nguyen, Binghua Hao, et al.
Journal of Global Antimicrobial Resistance|April 8, 2024
Real-world evaluation of imipenem/cilastatin/relebactam across US medical centresRyan K Shields, Emre Yücel, Vladimir Turzhitsky, et al.
Open Forum Infectious Diseases|January 15, 2021
Discordance Among Antibiotic Prescription Guidelines Reflects a Lack of Clear Best PracticesLauren M Rost, M Hong Nguyen, Cornelius J Clancy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeRyan K Shields, Alina Iovleva, Ellen G Kline, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2011
Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serumRyan K Shields, M Hong Nguyen, Chen Du, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistanceRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Infectious Diseases and Therapy|May 31, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysisRyan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 18, 2021
Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysisSunish Shah, Derek N Bremmer, Ellen G Kline, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2025
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative MeningitisAlice J Hsu, Kathleen Chiotos, Emily L Heil, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2025
Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremiaSunish Shah, Lloyd G Clarke, Bonnie A Falcione, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam ResistanceRyan K Shields, M Hong Nguyen, Binghua Hao, et al.
Journal of Global Antimicrobial Resistance|April 8, 2024
Real-world evaluation of imipenem/cilastatin/relebactam across US medical centresRyan K Shields, Emre Yücel, Vladimir Turzhitsky, et al.
Open Forum Infectious Diseases|January 15, 2021
Discordance Among Antibiotic Prescription Guidelines Reflects a Lack of Clear Best PracticesLauren M Rost, M Hong Nguyen, Cornelius J Clancy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeRyan K Shields, Alina Iovleva, Ellen G Kline, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2011
Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serumRyan K Shields, M Hong Nguyen, Chen Du, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistanceRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Infectious Diseases and Therapy|May 31, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysisRyan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Pageof 20